|
| Exchange Disseminated Time 26/05/2016 17:31:45 | Mangalam Drugs & Organics Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on June 06, 2016, inter alia, to consider and approve the allotment of 14,50,000 Equity Shares on conversion of remaining 14,50,000 Share Warrants which were allotted on preferential basis to Shri JB Pharma LLP, (“Promoter’' or “Proposed Allottee”) on September 28, 2015 and the issue of which was approved by the shareholders at 42nd Annual General Meeting of the Company held on September 03, 2015., in Compliance with SEBI (ICDR) Regulations, 2009, Companies Act, 2013 and other applicable laws, rules and regulations.
Further, as per the SEBI (Prohibition of Insider Trading) Regulations, 2015 and in terms of the Company’s Code of Conduct for Regulating, Monitoring, and Reporting Trading By Insiders, the ‘Trading Window’ tor dealing in Equity Shares of the Company shall remain closed from closing hours of May 26, 2016 till the expiry of 48 hours from the time the Outcome is communicated to the Stock Exchanges on the date of the Meeting i.e. June 06, 2016. |
|
|